District Court, D. Delaware August 30, 2002, No. MDL 98-1232-SLR (In re Warfarin Sodium Antitrust Litigation)

OPINION

SUE L. ROBINSON, Chief Judge.

1. INTRODUCTION

On March 30, 2001, consumers and third-party payors (“TPPs”) who paid all or part of the purchase price of Coumadin® warfarin sodium1 filed a consolidated class action complaint alleging, individually and on behalf of all others similarly situated, that defendant DuPont Pharmaceuticals Company2 (“DuPont”) caused them to overpay for Coumadin as